Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Peptide Histidine-Methionine (human) monoclonal antibody (3)

 
BPD-ABS-020-03-04 400 µg 1,320.00 USD
 
BPD-ABS-020-03-1 1 mg 2,585.00 USD
Do you need bulk/larger quantities?
 

Product Details

Alternative Name:PHM
 
Clone:3
 
Host:Mouse
 
Isotype:IgG2a
 
Immunogen:Synthetic human peptide histidine-methionine.
 
UniProt ID:P01282
 
GenBank ID:7432
 
Source:From culture supernatant.
 
Species reactivity:Human
 
Crossreactivity:Cross-reacts with PACAP (approximately 12%; incomplete, non-parallel inhibition). ABS 020-03 does not cross-react with GLP-1, GLP-2, VIP or glucagon.
 
Applications:ELISA, IHC
 
Purity Detail:Protein A/G-purified.
 
Formulation:Liquid. In 0.01M phosphate buffer, pH 7.4, containing 0.5M sodium chloride and 15mM sodium azide.
 
Shipping:Blue Ice Not Frozen
 
Long Term Storage:+4°C
 
Scientific Background:Human peptide histidine-methionine (PHM) is a 27-amino-acid peptide belonging to the glucagon-secretin family of peptide hormones. PHM is produced from the same prohormone as VIP, with which it shows considerable sequence homology. The VIP/PHM prohormone is produced by neurons in the central and peripheral nervous systems, often together with acetylcholine. In some situations, the peptides reinforce and prolong the effects of neurotransmitter release. Like VIP, PHM is a vasodilator and stimulator of intestinal fluid secretion. High plasma levels of PHM are diagnostic of the corresponding peptide-producing tumor (VIPoma), associated with the watery diarrhea-hypokalemia-achlorhydria syndrome.
 
Regulatory Status:RUO - Research Use Only
 

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
Vasoactive intestinal (poly)peptide
By biological activity:
Vasoactive intestinal (poly)peptide Monoclonal antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
Keep in touch

©2021 Enzo Life Sciences, Inc.,